GBA1 and Parkinson disease: For reasons that are not understood, homozygous and heterozygous carriers of GBA1 mutations have between 5- and 30-fold increased risk for developing Parkinson’s disease (PD), depending on age, ethnicity, and the severity of the mutation (1, , –4).